Abstract
Trans-urocanic acid (trans-UCA) is synthesized in the skin, liver, and brain. It is a major natural moisturizing factor in skin and maintains its acid pH. In skin, it isomerizes to cis-UCA following exposure to UVR. Both isomers fulfill multiple roles in health and disease. Cis-UCA has immunomodulatory properties linked with several cutaneous diseases such as skin cancer, atopic dermatitis, and urticaria and associates with systemic diseases including multiple sclerosis. The levels of UCA in the skin, brain, urine, and feces reflect some physiological processes and may be disease biomarkers. Both isomers of UCA have therapeutic potential for a range of disorders.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Brain / immunology
-
Brain / pathology
-
Carcinogenesis / drug effects
-
Carcinogenesis / immunology
-
Carcinogenesis / radiation effects
-
Dermatitis, Atopic / drug therapy
-
Dermatitis, Atopic / immunology
-
Dermatitis, Atopic / pathology
-
Humans
-
Hydrogen-Ion Concentration
-
Liver / chemistry
-
Liver / immunology
-
Liver / pathology
-
Multiple Sclerosis / drug therapy
-
Multiple Sclerosis / immunology
-
Multiple Sclerosis / pathology
-
Signal Transduction / immunology
-
Signal Transduction / radiation effects
-
Skin / chemistry
-
Skin / immunology*
-
Skin / pathology
-
Skin / radiation effects
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / immunology
-
Skin Neoplasms / pathology
-
Stereoisomerism
-
Ultraviolet Rays / adverse effects
-
Urocanic Acid / chemistry
-
Urocanic Acid / metabolism*
-
Urocanic Acid / radiation effects
-
Urocanic Acid / therapeutic use
-
Urticaria / drug therapy
-
Urticaria / immunology
-
Urticaria / pathology